Angiotensinogen promoter variants influence gene expression in human kidney and visceral adipose tissue

Journal of Human Hypertension

Volumn 24, Issue 3, 2010, Pages 213-219

  Sarzani, R ^a   Bordicchia, M ^a   Marcucci, P ^a   Minardi, D ^a   Muzzonigro, G ^a   Dessi Fulgheri P ^a   Rappelli, A ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Essential hypertension; Human angiotensinogen gene; Kidney; Obesity; Visceral adipose tissue

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GENE EXPRESSION; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HUMAN TISSUE; INTRAABDOMINAL FAT; KIDNEY CORTEX; KIDNEY MEDULLA; NEPHRECTOMY; NUCLEOTIDE SEQUENCE; OBESITY; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM ABSORPTION; TISSUE DISTRIBUTION;

AGED; ANGIOTENSINOGEN; BASE SEQUENCE; FEMALE; GENE EXPRESSION; GENOTYPE; HUMANS; HYPERTENSION, RENAL; INTRA-ABDOMINAL FAT; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OBESITY; ORGAN SPECIFICITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RNA, MESSENGER;

EID: 77249107023     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2009.48     Document Type: Article

References (29)

1. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-180.
2. Corvol P, Jeunemaitre X. Molecular genetics of human hypertension: role of AGT. Endocr Rev Endocr Rev 1997; 18: 662-677.
3. Dickson ME, Sigmund CD. Genetic basis of hypertension: revisiting angiotensinogen. Hypertension 2006; 48: 14-20.
4. Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R. M235T angiotensinogen polymorphism and cardiovascular renal risk. J Hypertens 1999; 17: 9-17.
5. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99: 1786-1797.
6. Sarzani R, Dessì-Fulgheri P, Mazzara D, Catalini R, Cola G, Bersigotti G et al. Cardiovascular phenotype of young adults and angiotensinogen alleles. J Hypertens 2001; 19: 2171-2178.
7. Pereira TV, Nunes AC, Rudnicki M, Yamada Y, Pereira AC, Krieger JE. Meta-analysis of the association of 4 angiotensinogen polymorphisms with essential hypertension: a role beyond M235T? Hypertension 2008; 51: 778-783.
8. Jain S, Li Y, Patil S, Kumar A. A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity. J Mol Med 2005; 83: 121-131.
9. Zhao YY, Zhou J, Narayanan CS, Cui Y, Kumar A. Role of C/A polymorphism at-20 on the expression of human angiotensinogen gene. Hypertension 1999; 33: 108-115.
10. Dickson ME, Zimmerman MB, Rahmouni K, Sigmund CD. 20 and-217 promoter variants dominate differential angiotensinogen haplotype regulation in angiotensinogen-expressing cells. Hypertension 2007; 49: 631-639.
11. Cooper R, McFarlane-Anderson N, Bennett FI,Wilks R, Puras A, Tewksbury D et al. ACE, angiotensinogen and obesity: a potential pathway leading to hypertension. J Hum Hypertens 1997; 11: 107-111.
12. van Harmelen V, Elizalde M, Ariapart P, Bergstedt-Lindqvist S, Reynisdottir S, Hoffstedt J et al. The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity. Int J Obes Relat Metab Disord 2000; 24: 673-678.
13. Rahmouni K, Mark AL, Haynes WG, Sigmund CD. Adipose depot-specific modulation of angiotensinogen gene expression in diet-induced obesity. Am J Physiol Endocrinol Metab 2004; 286: E891-E895.
14. Ingelfinger JR, Schunkert H, Ellison KE, Pivor M, Zuo WM, Pratt R et al. Intrarenal angiotensinogen: localization and regulation. Pediatr Nephrol 1990; 4: 424-428.
15. Peti-Peterdi J, Warnock DG, Bell PD. Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT1 receptors. J Am Soc Nephrol 2002; 13: 1131-1135. (Pubitemid 34441392)
16. Sarzani R, Cusi D, Salvi F, Barlassina C, Macciardi F, Pietrucci F et al. The 460Trp allele of alpha-adducin increases carotid intima-media thickness in young adult males. J Hypertens 2006; 24: 697-703.
17. Sarzani R, Fallo F, Dessi-Fulgheri P, Pistorello M, Lanari A, Paci VM et al. Local renin-angiotensin system in human adrenals and aldosteronomas. Hypertension 1992; 19: 702-707.
18. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59: 251-287.
19. Paul M, Mehr AP, Kreutz R. Physiology of local reninangiotensin systems. Physiol Rev 2006; 86: 747-803.
20. Navar LG, Nishiyama A. Why are angiotensin concentrations so high in the kidney? Curr Opin Nephrol Hypertens 2004; 13: 107-115.
21. Nakajima T, Wooding S, Sakagami T, Emi M, Tokunaga K, Tamiya G et al. Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world. Am J Hum Genet 2004; 74: 898-916.
22. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet JT, Powers M et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997; 60: 1448-1460.
23. Sherman CT, Brasier AR. Role of signal transducers and activators of transcription 1 and-3 in inducible regulation of the human angiotensinogen gene by interleukin-6. Mol Endocrinol 2001; 15: 441-457.
24. Jain S, Shah M, Li Y, Vinukonda G, Sehgal PB, Kumar A. Upregulation of human angiotensinogen (AGT) gene transcription by interferon-gamma: involvement of the STAT1-binding motif in the AGT promoter. Biochim Biophys Acta 2006; 1759: 340-347.
25. Engeli S, Sharma AM. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med 2001; 79: 21-29.
26. Sarzani R, Salvi F, Dessì-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens 2008; 26: 831-843.
27. Saint-Marc P, Kozak LP, Ailhaud G, Darimont C, Negrel R. AngiotensinII asatrophic factor of white adipose tissue: stimulation of adipose cell formation. Endocrinology 2001; 142: 487-492.
28. Jones BH, Standridge MK, Moustaid N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 1997; 138: 1512-1519.
29. Darimont C, Vassaux G, Ailhaud G, Negrel R. Differentiation of pre-adipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II. Endocrinology 1994; 135: 2030-2036.